Inhibitors of V-type ATPases, bafilomycin A1 and concanamycin A, protect against beta-amyloid-mediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction (Q50519141)
scientific article published in May 1999
Language:
Current Data About Inhibitors of V-type ATPases, bafilomycin A1 and concanamycin A, protect against beta-amyloid-mediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction
(P31) (Q13442814)
(P248)
(P698) 10217271
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10217271

(P304) 1939-1947
(P248)
(P698) 10217271
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10217271

(P407) (Q1860)

(P433) 5
(P248)
(P698) 10217271
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10217271

(P478) 72
(P248)
(P698) 10217271
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10217271

(P577) Saturday, May 1, 1999
(P248)
(P698) 10217271
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10217271

(P1433) (Q6295643)
(P248)
(P698) 10217271
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10217271

(P1476) "Inhibitors of V-type ATPases, bafilomycin A1 and concanamycin A, protect against beta-amyloid-mediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction" (language: en)
(P248)
(P698) 10217271
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10217271

(P2093) M D Kane
(P1545) 1
(P248)
(P698) 10217271
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10217271

R D Schwarz
(P1545) 2
(P248)
(P698) 10217271
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10217271

L St Pierre
(P1545) 3
(P248)
(P698) 10217271
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10217271

M D Watson
(P1545) 4
(P248)
(P698) 10217271
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10217271

M R Emmerling
(P1545) 5
(P248)
(P698) 10217271
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10217271

P A Boxer
(P1545) 6
(P248)
(P698) 10217271
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10217271

G K Walker
(P1545) 7
(P248)
(P698) 10217271
(P813) Wednesday, March 14, 2018
(P854) http://europepmc.org/abstract/MED/10217271

(P2860) (Q53182604)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q41612821)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q41460857)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q33661004)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q24631987)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q54658808)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q24561804)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q41359135)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q44302226)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q37149874)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q41370385)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q48537368)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q25939005)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q48933977)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q41438119)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q46598331)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q41189072)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q41205433)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q39115574)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q24314906)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q24319073)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q46238580)
(P248)
(P854) https://api.crossref.org/works/10.1046%2FJ.1471-4159.1999.0721939.X
(P813) Sunday, January 21, 2018

(Q70713820)
(P248)
(P813) Friday, April 12, 2024
(P854) https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.37.1333

other details
description scientific article published in May 1999

External Links
(P356) 10.1046/J.1471-4159.1999.0721939.X
(P698) 10217271
(P5875) 247661524